Key result
High expression of CDK1 was identified as an independent prognostic factor for poor overall survival (HR 10.031) in adult patients with adrenocortical carcinoma.
Why the study?
Metastasis in adrenocortical carcinoma presents a clinical challenge due to limited mechanistic insights and few effective treatment options.
Observational (n=73)
Hazard Ratio: 10.031 (95% CI 2.499–40.26)
p-value: p=<0.001
Seven hub genes were identified as significantly associated with metastasis and poor prognosis in adult adrenocortical carcinoma, offering potential novel therapeutic targets.
Should not yet change practice in ACC; leaves open these hub genes as candidate prognostic markers and therapeutic targets.
Background: Metastasis in adrenocortical carcinoma (ACC) presents a formidable clinical challenge, with limited insights into its underlying mechanisms and few effective treatment options. This study aimed to identify molecular markers associated with metastasis in adult ACC and to explore novel therapeutic approaches. Methods: RNA sequencing data from 74 adult ACC patients were analyzed using bioinformatics approaches, including weighted gene co-expression network analysis (WGCNA) and differential gene expression analysis. Functional pathway enrichment analyses were conducted to identify metastasis-associated genes and to explore key biological pathways contributing to metastatic progression. Candidate genes were selected based on their statistical significance, prognostic relevance, and involvement in metastatic processes. Results: Seven hub genes were identified as significantly associated with metastasis and poor prognosis in ACC patients. These genes were enriched in pathways critical to tumor progression, such as mismatch repair, nucleotide excision repair, and cell cycle regulation. High expression levels of these genes correlated with reduced overall survival. Importantly, potential therapeutic agents targeting these molecular drivers were identified, offering promising, lower-toxicity options for treating metastatic ACC. Conclusion: The molecular markers identified in this study offer valuable insights into the mechanisms underlying ACC metastasis and represent promising therapeutic targets, providing a foundation for developing improved treatment strategies in clinical practice.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2025) conducted an observational in Adrenocortical carcinoma (n=73). High expression of CDK1 vs. Low expression of CDK1 was evaluated on Overall survival (HR 10.031, 95% CI 2.499-40.260, p=<0.001). High expression of CDK1 was identified as an independent prognostic factor for poor overall survival (HR 10.031) in adult patients with adrenocortical carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: